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Abstract Lipid droplets (LDs) are composed of
neutral lipids enclosed in a phospholipid monolayer,
which harbors membrane-associated proteins that
regulate LD functions. Despite the crucial role of LDs
in lipid metabolism, remodeling of LD protein
composition in disease contexts, such as steatosis,
remains poorly understood. We hypothesized that
chronic ethanol consumption, subsequent abstinence
from ethanol, or fasting differentially affects the LD
membrane proteome content and that these changes
influence how LDs interact with other intracellular
organelles. Here, male Wistar rats were pair-fed
liquid control or ethanol diets for 6 weeks, and
then, randomly chosen animals from both groups
were either refed a control diet for 7 days or fasted
for 48 h before euthanizing. From all groups, LD
membrane proteins from purified liver LDs were
analyzed immunochemically and by MS proteomics.
Liver LD numbers and sizes were greater in ethanolfed rats than in pair-fed control, 7-day refed, or fasted rats. Compared with control rats, ethanol feeding
markedly altered the LD membrane proteome,
enriching LD structural perilipins and proteins
involved in lipid biosynthesis, while lowering LD
lipase levels. Ethanol feeding also lowered LDassociated mitochondrial and lysosomal proteins. In
7-day refed (i.e., ethanol-abstained) or fasted-ethanolfed rats, we detected distinct remodeling of the LD
proteome, as judged by lower levels of lipid biosynthetic proteins, and enhanced LD interaction with
Our study reveals
mitochondria and lysosomes.
evidence of significant remodeling of the LD membrane proteome that regulates ethanol-induced steatosis, its resolution after withdrawal and abstinence,
and changes in LD interactions with other intracellular organelles.
Supplementary key words Ethanol • steatosis • lipid droplet •
fasting • proteomics • liver • MS • immunohistochemistry •
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Fatty liver (steatosis) is the earliest response by the
liver to heavy alcohol (ethanol) consumption (1). However, steatosis is reversible after abstinence from
ethanol (2). During continuous (chronic) alcohol (ab)
use, fat/lipid that accumulates in the liver reacts with
free radicals and other secondary ethanol metabolites
generated during ethanol metabolism. These eventually trigger subsequent reactions that damage other
biomolecules and organelles and disrupting their
biogenesis (3). Thus, with continued heavy drinking,
hepatic steatosis can worsen liver damage that progresses to hepatitis, fibrosis, and cirrhosis (1).
Ethanol-induced fatty liver is a consequence of dysregulation, induced by ethanol, of several cellular
mechanisms (1). Hepatic ethanol metabolism lowers the
hepatic NAD+/NADH ratio, which initiates significant
metabolic shifts toward reductive synthesis to accelerate the synthesis and slow the oxidation of fatty acids
(3, 4). Ethanol induces de novo lipogenesis by activating
sterol regulatory element binding protein 1c, carbohydrate response element binding protein, and early
growth response-1, each of which stimulates transcription of specific genes involved in lipid biosynthesis (4).
Hepatic ethanol oxidation simultaneously disrupts fatty
acid oxidation by downregulating the PPAR-α, a transcription factor that activates genes involved in fatty
acid oxidation (1). The end result of these changes is
hepatic steatosis. The latter is exacerbated by enhanced
uptake of serum fatty acids generated by ethanolinduced acceleration of adipose tissue lipolysis and
deceleration of hepatic lipolysis and lipophagy, both
pathways of lipid droplet (LD) catabolism (2).
LDs in liver cells appear histologically as unstained,
sharply defined cytoplasmic vacuoles, which contain
neutral lipids enclosed by a single phospholipid membrane that harbors integral and peripheral proteins (5).
Those proteins are synthesized on either the endoplasmic reticulum (ER) membrane or recruited directly
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from the cytosol to the LD membrane (6). All these
proteins collectively form the LD membrane proteome,
which is represented by enzymes of lipid metabolism,
the perilipin (PLIN) family, membrane trafficking
proteins, and proteins involved in degradation pathways that regulate distinct LD functions. These include
enzymes that liberate fatty acids for energy, membrane
biosynthesis, lipid signaling, and sequestration and reesterification of fatty acids into triglycerides (TGs)
(6).Other LD membrane proteins have key roles in
creating protein-based tethering complexes to maintain
interorganelle contact sites (6). Although these latter
proteins are bona fide LD membrane proteins, others
transiently localize to LD membranes, depending on
the metabolic state of the cell.
The complement of hepatic LD membrane proteins
likely changes after chronic alcohol consumption, as
other studies reveal that the LD membrane proteome is
altered in livers of rodents fed a high-fat diet (7, 8). Here,
we report studies that similarly examined whether the
liver LD membrane proteome undergoes remodeling
after chronic ethanol feeding. We compared the LDs
from livers from rats chronically fed an ethanol diet with
hepatic LDs from rats pair-fed a control diet, from
ethanol-fed rats abstained from ethanol and then refed a
control diet for 7 days, and from control and ethanol-fed
rats that were subjected to a 48-h fast. We sought to
determine whether these treatments altered the LD
membrane proteome and whether such changes correspond to the status of fat accumulation in the liver. Here
we report that all these interventions induced dynamic
changes in the LD membrane proteome that corresponded to previously reported changes in lipid metabolic processes in the livers of ethanol-fed animals (1, 2,
9–11). Such changes were partially or wholly reversible
after cessation of ethanol consumption or fasting.

MATERIALS AND METHODS
Reagents
Antibodies to PLIN-3, LAMP1, LAMP2A, HSC70, cytochrome c oxidase subunit IV (COXIV), phosphorylated
adipocyte TG lipase (pATGL), phosphorylated hormonesensitive lipase (pHSL), and mitochondria isolation and mitochondrial complex I activity assay kits were obtained from
Abcam (Cambridge, MA). The lysosome isolation kit was from
Invent Biotechnologies (Plymouth, MN). Antibodies to
hydroxysteroid 17β-dehydrogenase 11 (HSD17β11), hydroxysteroid 17β-dehydrogenase 13 (HSD17β13), and cell death–inducing
DFFA-like effector B (CIDEB) were from were from MyBioSource (San Diego, CA). Anti-PLIN-5 was from Santa Cruz
Biotechnology, Inc. (Dallas, TX). We purchased a protease inhibitor cocktail, deubiquitylase inhibitors, and other specialized
reagents from Sigma (St. Louis, MO).

Animal treatments
All protocols were approved by the IACUC at the VA
Nebraska, Western Iowa Health Care System Research
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Service. We followed the eighth edition of the Guidelines for
the Use and Care of Laboratory Animals, published by the
National Institutes of Health. Male Wistar rats, weighing
175–200 g, purchased from Charles River Laboratories
(Portage, MI) were weight-matched and fed control or
ethanol-containing Lieber-DeCarli diets for 6 weeks. Then,
randomly chosen ethanol-fed rats were gradually weaned
from the ethanol diet (to avoid withdrawal symptoms) and
fed ethanol-free control diet, as described (2) or they (and
pair-fed control animals) were fasted for 48 h. At euthanasia,
we collected blood from the axillary vessels of each rat while
it was under isoflurane anesthesia. After exsanguination and
pneumothorax, the liver of each animal was removed and a
portion of the tissue was subjected to mitochondrial and
lysosomal isolation according to manufacturer's protocol. For
MS proteomics analyses, we used three rats per group. For
other measurements, the number of animals is stated in the
figure legends.

Serum analyses
We measured the levels of NEFA in sera, using a colorimetric assay kit from Cell Biolabs, Inc. (San Diego, CA).

Hepatic TGs
Preweighed frozen liver pieces were subjected to total lipid
extraction. The filtered lipid extracts were saponified to
quantify TGs using a Thermo DMA reagent (Thermo Electron Inc., Middletown, VA). Results are stated as mg TG (using
a triolein standard) and normalized per gram of the liver.

LD isolation
LDs from crude liver homogenates were purified by
gradient centrifugation as described earlier (2) with slight
modifications. Briefly, post–nuclear supernatant fractions
were obtained by centrifugation (1,000g for 10 min) of 20%
liver homogenates in 60% sucrose (w/v) in Tris/EDTA (TE)
buffer (10 mM Tris HCl, pH 7.4, 1 mM EDTA) containing
phosphatase, protease, and deubiquitylase inhibitors. LDs
were isolated by subjecting post–nuclear supernatant fractions to discontinuous sucrose gradient ultracentrifugation
using a SW-28 rotor (30,000g for 30 min) as described (2). The
white band (LD fraction) at the top of the gradient was
collected and further purified by centrifugation (30,000g) for
30 min in TE buffer. LDs obtained from the latter steps were
subjected to three additional centrifugations (20,800g) for
10 min each, to remove loosely bound and/or contaminating
proteins and copurifying membranes (12, 13). Purity of isolated LDs was confirmed by the absence of commonly copurifying membranes by Western blot (WB) (Supplemental
Fig. S1), as we described before (14). To concentrate LDs, the
clear buffer underlying the LDs white band was removed and
the LD fraction was brought up to 200 μl with TE buffer,
containing the inhibitors mentioned above.

Detection of proteins on WBs
LD fractions were subjected to BCA protein quantification.
Proteins were separated by electrophoresis under denaturing
conditions on SDS-polyacrylamide minigels and transferred
onto nitrocellulose membranes as described before (2, 15, 16).
To determine equal protein load, the membranes were
stained with Ponceau S and protein load quantified by
densitometry (Supplemental Fig. S1). We further incubated

the membranes overnight with primary antibodies at 4◦ C.
After washing, membranes were incubated with secondary
antibodies conjugated to green or red infrared dye for 1 h.
Proteins were detected using the Odyssey infrared imaging
system. We quantified protein band densities with LI-COR®
analysis software. Levels of Plin-2, a major LD membrane
protein were comparable in LD fractions from different
experimental groups after equal protein load (Supplemental
Fig. S1). Thus, Plin-2 was used as the normalizer for protein
quantification.

Sample preparation, LC-MS, and protein
quantification and identification
LD proteins were electrophoretically run into the top
portion of a 12% acrylamide gel under reducing conditions
(15, 16). The gels were then fixed and stained with colloidal
Coomassie Brilliant Blue G. The large dark single band of
protein near the top of the gel was excised and reduced by
incubation with DTT and then alkylated with iodoacetamide before washing with 50 mM ammonium bicarbonate
in 50% acetonitrile to remove SDS and stain, before protein
digestion with trypsin (1 μg trypsin per 20 μg sample protein) for 16 h at 37◦ C (15, 16). Peptide spectra were acquired
on a Q-Exactive-HF (Thermo Fisher Scientific, Waltham,
MA), with an online U3000 RSLCnano Liquid Chromatography system (Thermo Fisher Scientific). MS was conducted
in a top 15 data-dependent acquisition mode triggering on
peptides with charge states 2 to 5 over the mass range of
375–1,500 m/z. The online peptide separation was carried
out by first loading the sample isocratically onto a trapping
column (C18 Acclaim™ PepMap™100 C18 0.075 × 20 mm,
3 μm, 100 Å) at 5 μl/min in 1.5% acetonitrile, 0.2% formic
acid. After 2.8 min, this was then switched in-line with the
nano-column and peptides were separated on a 75 μm ×
25 cm peptide CSH™ C18 130A, 1.7 μm resolving nanocolumn (Waters Corp, Milford, MA) using a linear
gradient run at 260 nl/min from 5% B to 32% B over
96 min where A is water and 0.1% formic acid and B is 80%
acetonitrile and 0.1% formic acid. Protein identification was
performed by searching MS/MS data against the Swiss-Prot
Rattus norvegicus protein database downloaded on February
13, 2019, using the in-house Mascot 2.6.2 (Matrix Science
Ltd., London, UK) search engine. The rat database has
36,159 entries. The search was set up for full tryptic peptides with a maximum of two missed cleavage sites. Acetylation of protein N-termini and oxidized methionine was
included as variable modifications, and carbamidomethylation of cysteine was set as a fixed modification. The precursor mass tolerance threshold was set to 10 ppm, and the
maximum fragment mass error was 0.02 Da. The significance threshold of the ion score was calculated based on a
false discovery rate (FDR) of ≤1%. We calculated the FDR
by the decoy fusion method using PEAKS studio software.
Label-free quantitative analysis and peak list generation
were performed using Progenesis QI-P 4.2 (Nonlinear Dynamics, Newcastle, United Kingdom) to conduct comparative proteomics. We quantified fold changes (increase or
decrease) in protein expression induced by ethanol feeding,
refeeding control diet, and fasting control and ethanol-fed
rats by comparing datasets from each of the aforementioned treatment groups with the dataset of the pair-fed
control group. We used 3 biological replicates per group,
and each sample was run once for MS proteomics. Statistical analyses were performed using ANOVA and the
Benjamini-Hochberg method was used to adjust P values for

the multiple testing–caused FDR. The adjusted P ≤ 0.05 was
considered significant.

Bioinformatic analysis
Ingenuity pathway analysis (IPA) (QIAGEN) was used to
identify enriched biological function (BF), canonical pathway
categories, and regulatory networks of LD membraneassociated proteins. The Gene Ontology (GO) analysis and
network for control LD proteome were constructed using
Cytoscape 3.7.0 software with the ClueGo plugin.

Immunofluorescence studies
Liver sections were fixed in 10% formalin, embedded in
paraffin, cut into sections (4 μm), and mounted onto slides.
After deparaffinization, tissue sections were incubated with
either anti-COXIV and anti-Plin-2 or anti-LAMP1 and antiPlin2, followed by incubation with secondary antibodies
(goat anti-rabbit (Alexa Fluor 555) and goat anti-mouse secondary antibody (Alexa Fluor 488)). All images were obtained
with a fluorescence-detecting microscope. Fluorescence intensities of staining and lysosome numbers were quantified in
multiple images using NIH ImageJ analyzer software.

Statistical analysis
Data are expressed as the mean values ± SEM. We determined statistical significance between groups by one-way
ANOVA, using a Newman-Keuls post hoc analysis. A P
value ≤ 0.05 was considered statistically significant.

RESULTS
Refeeding or fasting after ethanol withdrawal
attenuated hepatic steatosis
We tested whether refeeding ethanol-fed rats the
liquid control diet for 7 days (i.e., “7-day refed”) or
fasting them for 48 h (i.e., “ethanol-fast”) after ethanol
withdrawal attenuates alcohol-induced fatty liver. Liver
sections of ethanol-fed rats clearly showed greater
numbers of LDs with larger volumes than those of pairfed controls (Fig. 1A). TG levels in livers of ethanol-fed
rats were 3-fold higher than in pair-fed controls and
verified the histological findings (Fig. 1B). In sera of
ethanol-fed rats, we also detected 1.6-fold higher levels
of NEFAs than in pair-fed controls (Fig. 1C). Circulating
NEFAs reportedly exacerbate ethanol-induced fatty
liver, as they are actively transported into liver cells and
re-esterified into TGs (2, 17). In 7-day refed rats, serum
NEFAs fell to control levels (Fig. 1C), and while their
liver TGs levels declined, they remained significantly
higher than in pair-fed controls (Fig. 1B). Compared
with rats continuously pair-fed control diet, “controlfasted” rats exhibited 1.4-fold higher levels of both
hepatic TGs and serum NEFA levels. Serum NEFA
levels in “ethanol-fasted” rats remained unchanged
compared with their former ethanol-fed state (Fig. 1B).
Liver TGs in these animals remained significantly (1.5fold) higher than controls.
Ethanol and hepatic lipid droplet proteome
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Fig. 1. Refeeding and fasting after ethanol withdrawal attenuates hepatic steatosis. A: H&E-stained paraffin section images obtained by light microscopy (B) liver triglycerides and (C) serum NEFA levels from rats treated as indicated in abscissa. Data are the
mean values of ± SEM of 6–14 animals per group. Bars sharing different letters are significantly different. Bars sharing the same
letter are not significantly different, P ≤ 0.05.

Refeeding or fasting after ethanol withdrawal
attenuated LD-associated proteins that participate in
lipid accumulation and/or LD utilization
LD membrane-associated proteins regulate distinct
LD functions. Here, using highly enriched
(Supplemental Fig. S1) LDs isolated from livers of control, ethanol-fed, 7-day refed, control-fast, and ethanolfast rats, we measured the contents of selected LD
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membrane proteins that reportedly regulate LD metabolism. We sought to determine whether expression of
these proteins correlates with the status of hepatic fat
accumulation. Compared with hepatic LD fractions
from pair-fed controls (henceforth, “control(s)”), the
levels of the LD membrane proteins Plin-3 and Plin-5
(18) were both 1.8-fold higher in LD fractions from
ethanol-fed rats (Fig. 2A, B, F, I). Plin-3 levels in LD

Fig. 2. Refeeding and fasting after ethanol withdrawal attenuates LD proteins that participate in lipid accumulation and those that
promotes LD utilization. (A–E) Representative Western blots and (F–O) quantification of indicated proteins in lipid droplets isolated
from the livers of animals treated as described in the abscissa. Data are the means ± SE of 6–8 animals/group. Bars with different
letters are significantly different. Bars with the same letter are not significantly different, P ≤ 0.05. LD, lipid droplet.

fractions of 7-day refed rats returned to control levels,
but refeeding caused only a partial decline in Plin-5
levels previously induced by ethanol feeding (Fig. 2A,
B, F, I). Plin-5, but not Plin-3, levels were higher in hepatic LDs of control-fast (C-fast) than in LDs of controls, but this Plin-5 level in control-fast animals was 1.4fold lower than that in LDs of ethanol-fed rats. Both
Plin-3 and Plin-5 levels induced by 6 weeks of chronic

ethanol feeding were significantly lower in hepatic LDs
of “ethanol-fast” rats (Fig. 2A, B, F, I). HSD17β13 and
HSD17β11, both implicated in promoting lipogenesis
and LD aggregation, respectively (19–21), were each 2.4fold higher in LDs of ethanol-fed rats than those from
controls (Fig. 2A, C, G, H). Both proteins declined to
control levels in LDs from 7-day refed rats, as well as
“control-fast” and “ethanol-fast” animals (Fig. 2A, C, G,
Ethanol and hepatic lipid droplet proteome
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H). Compared with LD fractions from control rats, the
levels of CIDEB, which induces LD fusion (18), causing
their enlargement, were ∼1.8-fold higher in LDs of
ethanol-fed rats (Fig. 2C, J). CIDEB levels decreased
numerically but not significantly after 7-day refeeding
and remained comparable with levels in both control
and ethanol-fed rats. Compared with controls, “controlfast” and “ethanol-fast” did not change LD-associated
CIDEB levels (Fig. 2C, J).
To ascertain LD interaction with other intracellular
compartments, we measured the levels of lysosomeassociated membrane protein (LAMP) 1 (LAMP1),
LAMP2A, and heat shock cognate protein 70 (HSC70).
LAMP1 levels indicate intracellular lysosome content
(22). LAMP2A and HSC70 coordinate chaperonemediated autophagy, the lysosomal degradation of
signal-bearing target proteins that bind HSC70, a
chaperone that mediates their transfer to the lysosome,
where lysosome internalization of the target protein is
facilitated by LAMP2A. (23). Compared with LDs from
controls, LDs from ethanol-fed rats exhibited 3.3-, 2.3-,
and 1.5-fold lower levels of LAMP1, LAMP2A, and
HSC70, respectively (Fig. 2C, D, K, L, M). Seven-day
refeeding after ethanol withdrawal partially restored
LAMP1, to near control levels while this treatment and
“ethanol-fast” fully restored LAMP2A and HSC70.
Compared with LAMP1 in control LDs, “control-fast”
significantly elevated LAMP1, whereas LAMP2A and
HSC70 were unaffected (Fig. 2C, D, K, L, M). We
measured HSL and ATGL, both of which catalyze TG
degradation (18). The total content of HSL protein
remained unchanged in hepatic LD fractions from all
experimental groups. Compared with controls, total
ATGL was significantly higher in LDs of ethanol-fed
rats but was unchanged in all other groups
(Supplemental Fig. S2G, H). Interestingly, however, the
active (phosphorylated) forms of both lipases (pHSL
and pATGL) were both two-fold lower in LDs of
ethanol-fed rats than those of controls (Fig. 2E, N, O).
However, after 7-day refeeding, control fast, and
ethanol fast, the levels of these phosphorylated lipases
in LDs were equal to each other and restored to control
levels (Fig. 2E, N, O).
LDs isolated from control rats revealed LDassociated proteome network
Quantification of selected LD membrane proteins
that regulate LD metabolism in livers of all five groups
of animals, revealed that, in general, the levels of those
proteins correlated with the degree of hepatic LD (fat)
accumulation (Figs. 1, 2). To further characterize the
dynamic changes in LD membrane-associated proteome that alter LD metabolism, we performed LC-MS
analyses to identify and quantify LD membrane proteins from each of the five animal groups. Our LC-MS
analyses identified 2,050 LD-associated proteins in
control animals (Supplemental Table S1). We compared
our dataset with the list of 1,428 LD proteins compiled
6
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from different proteomic studies of mammalian cells
and tissues, published by Khan et al., (7). Our dataset
contained 808 of those 1,428 proteins (Supplemental
Table S2). About 150 proteins from our dataset
(Supplemental Table S2; highlighted in yellow) that
were not found in the study by Khan et al., (7) list, were
those recently reported as LD interacting proteins by
Krahmer et al., (8), who investigated the hepatic
LD–associated proteome in mice challenged with a
high-fat diet (8). Our literature review also revealed that
many of our proteins that were not found in the list of
1,428 LD proteins mentioned above were found listed as
high-confident LD proteins by a study, which used
proximity labeling strategy to map the LD proteome
(24). The majority of unreported proteins in our dataset
belonged to the same protein family (i.e., execute
similar BF) that were previously reported. Although
our LD preparation is free (14) of some known markers
of other organelles (Supplemental Fig. S1), which would
suggest that our LD fraction is largely free of
contaminating proteins, we acknowledge that sucrose
centrifugation methods yield some contaminant proteins, as described in other LD proteomic studies (7, 12,
19, 25).
We next performed GO enrichment analysis with
ClueGo Cytoscape plug-in, to determine the functional
annotations of our hepatic LD-associated proteome. GO
analysis assigned control LD proteome to 58 terms in
biological process category (Supplemental Table S3).
Figure 3A shows the major biological process categories of the control LD proteome. Among those categories, the top five enriched terms, based on percent of
genes/proteins associated with a particular GO term,
were fatty acid catabolic processes (30.53%), fatty acid
oxidation (27.72%), oxidoreductase activity (26.43%), ER
to Golgi vesicle–mediated transport (23.58%), and carboxylic acid catabolic process (22.42%). In the cellular
component category, the top five enriched cellular
component categories (Fig. 3B) based on % terms per
group were cytoplasm (47.46%), intracellular organelle
(12.54%), ER membrane network (8.06%), organelle
membrane (7.76%), and endomembrane system (5.07%).
In the molecular function category, the five enriched
molecular function categories (Fig. 3C), based on %
terms per group, were nucleotide binding (35.42%),
anion binding (21.35%), coenzyme binding (5.73),
ATPase activity (5.73%), and electron transfer activity
(4.69%). Finally, to determine functionally enriched
pathways, we searched both Kyoto Encyclopedia of
Genes and Genomes and Wiki databases (Fig. 3D, E).
Pathways identified commonly by both pathway analyses were the PPAR signaling pathway, fatty acid
metabolic pathway, amino acid metabolic pathway, citrate cycle, and ribosomes. Unique pathways identified
by Kyoto Encyclopedia of Genes and Genomes analysis
were ferroptosis, peroxisome, bile acid biosynthesis,
fatty liver, thermogenesis, phagosome, ER protein processing, protein export, steroid biosynthesis and SNARE

Fig. 3. LD-associated proteome network from LDs of control rats. LD proteins are grouped into functional modules based on Gene
Ontology (GO) and pathway analysis. A: biological process, (B) cellular component, (C) molecular function, (D) Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathway, and (E) WiKi pathway analysis by ClueGo (Cytoscape) of control lipid droplet proteins. LD,
lipid droplet.

Ethanol and hepatic lipid droplet proteome
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interaction in vesicle transport. Unique pathways identified by Wiki analysis were mitochondrial long-chain
fatty acid beta oxidation, electron transport chain,
and oxidative phosphorylation, all indicating mitochondrial activity.
Chronic ethanol feeding altered LD membraneassociated proteins to affect their participating
pathways
To define ethanol-induced changes to the LDassociated proteome that contributed to hepatic steatosis, we first determined the fold changes in LD
membrane proteins induced by ethanol consumption.
Compared with controls, ethanol feeding significantly
(P < 0.05) altered the levels of 338 LD proteins (Fig. 4A
and Supplemental Table S4). Among those, 149 proteins, which appear red in the volcano plot (Fig. 4A),
were upregulated, whereas 189 proteins, which appear
green, were downregulated. The heat map in Fig. 4B
shows the status (red: upregulated; green: downregulated) of 48 frequently reported LD-associated
proteins. Here, we describe some of the major proteins that reportedly regulate LD metabolism. Plin-3,
CIDEB, and HSD17β13, which we found to be upregulated in hepatic LDs isolated from ethanol-fed rats
(Fig. 2), were similarly elevated by ethanol feeding
(Fig. 4B). Furthermore, downregulation by ethanol of
lysosomal integral membrane protein 2 (SCARB-2) and
of V-type proton ATPase 116 kDa subunit a isoform 1
(ATP6V0A1), which regulates vesicular acidification
(Fig. 4B), provided further evidence of lysosome-LD
interaction (Fig. 2). Ethanol feeding also increased the
levels of two ATGL inhibitors on LD membranes, the
G0/G1 switch protein 2 (G0s2) and Fas-associated factor
family member 2 (UBXD8). The former inhibits ATGL
TG hydrolase activity (Fig. 4B), whereas the latter enhances the LD size by blocking ATGL activity. Chronic
ethanol consumption also suppressed the level of LDassociated carcinoembryonic antigen-related cell adhesion molecule 1, which inhibits fatty acid synthase activity (18). This finding was associated with higher levels
of lanosterol synthase (LSS), squalene monooxygenase,
and hydroxysteroid 17β-dehydrogenase 7 (HSD17β7),
each of which participates in cholesterol biosynthesis
(18). Of note, although ethanol feeding downregulated
pHSL (Fig. 2E, N), it simultaneously elevated the levels
of its partner enzyme monoacylglycerol lipase, which
catalyzes monoglyceride hydrolysis (Fig. 4B). Next, using the IPA, we identified the canonical pathways to
which proteins, significantly altered by ethanol, were
assigned. In Fig. 4C, we show those that appeared
among the top 30 enriched pathways. Those proteins
that were significantly decreased (% decrease; appear in
green) were those involved in oxidative phosphorylation, other mitochondrial pathways and sirtuin pathways (Fig. 4C). Those proteins that were significantly
increased (% increases appear in red) were those
involved in cholesterol and steroid hormone
8
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biosynthesis (Fig. 4C). Because the prominent downregulated pathways all indicated mitochondrial
dysfunction, we identified, by IPA, those functions
specifically affected. Chronic ethanol feeding
decreased the levels (shown in green) of mitochondrial
complexes I, III, and IV, predominantly those associated with complex I (Fig. 4D).
Refeeding (7-day refed) and fasting (ethanol-fast)
after ethanol withdrawal caused distinct changes in
the LD membrane-associated proteome
To determine LD-associated proteome remodeling
associated with resolution of fatty liver by 7-day
refeeding or ethanol fast, we performed principal
component analyses (PCA) of datasets from LDs of our
five animal groups to visualize clustering of samples
within each group and overlap among groups. PCA
revealed control (blue), ethanol (green), and ethanolfast (purple) samples were clearly separated from
each other with no overlap (Fig. 5A). LDs from 7-day
refed rats (red) were separated from ethanol and
ethanol-fast but clustered with control samples.
Control-fast samples (yellow) showed larger intersample variation and resembled control, 7-day refed,
and ethanol-fed samples (Fig. 5A). We next, examined
individual LD proteins that were altered by refeeding
and ethanol fast. As described in the volcano plot
(Fig. 4A), ethanol feeding induced significant changes
in the LD-associated proteome. We then compared all
other groups to controls and found that 7-day refeeding significantly altered the levels of 93 proteins
(Supplemental Table S5). Among them, 68 proteins
were upregulated and 28 proteins were downregulated
(Fig. 5B). Compared with controls, control-fast rats
exhibited 245 proteins that were significantly altered of
which 53 proteins were upregulated and 192 proteins
were downregulated (Fig. 5C and Supplemental
Table S6). Compared with controls, ethanol-fast LDs
had significantly altered 448 proteins (Supplemental
Table S7), of which 270 were upregulated and 178
were downregulated (Fig. 5D). To determine how
changes in individual LD proteins contribute to the
status of hepatic fat accumulation, we first generated a
heat map (Fig. 5E) with some bona fide LD proteins and
with those that regulate lipogenesis and lipid catabolism
and are significantly altered by ethanol, 7-day refeeding, and ethanol fast. The heat map is shown in greenred color scale, where the intensities of green and red
represent the degree of downregulation and upregulation, respectively. Carcinoembryonic antigen-related
cell adhesion molecule 1, Plin-3, CIDEB, HSD17β7,
HSD17β13 and G0s2 proteins, each elevated by ethanol
feeding (Fig. 4B) were all normalized to control levels in
hepatic LDs from 7-day refed and ethanol-fast rats
(Fig. 5E). Proteins involved in steroid hormone
and cholesterol biosynthesis (26) including LSS,
HS17β7, HS17β11, hydroxysteroid 3β-dehydrogenase 7,
cytochrome b5 reductase 3, cytochrome P4502E1,

Fig. 4. Chronic ethanol feeding altered LD membrane proteins to affect their participating pathways. A: The volcano plot shows
the magnitude of fold changes in hepatic LD-associated proteins altered after chronic ethanol consumption by rats. B: The heat map
shows changes to frequently reported LD-associated proteins that are induced by chronic ethanol feeding by rats. (C) Top 30
enriched canonical pathways analyzed by Ingenuity Pathway Analysis (IPA) of hepatic LD-associated proteins that are modulated by
ethanol. (D) The schematic diagram shows how individual proteins of the top pathway (mitochondria) are affected (in green shade)
by chronic ethanol feeding in the rhombus-shaped outline. The volcano plot, IPA, and schematic diagram show significantly (P <
0.05) downregulated and upregulated proteins in green and red, respectively (top 30). LD, lipid droplet.

Ethanol and hepatic lipid droplet proteome

9

Fig. 5. Refeeding and fasting after ethanol withdrawal induced distinctive changes in LD membrane proteome content. A: Principal component analysis (PCA) compares control (blue), ethanol (green), 7-day (red), control-fast (yellow), and EtOH-fast (purple)
groups. Volcano plot show magnitude of fold changes of proteins significantly (P < 0.05) altered in LDs from (B) 7 days refed (C)
control fast, and (D) ethanol fast. E: The heat map show changes induced by ethanol and 7-day refeeding and fasting of ethanol-fed
rats after ethanol withdrawal, to selected bona fide and LD-associated lipid-metabolizing proteins. LD, lipid droplet.
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sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, delta (14)-sterol reductase (TM7SF2), and 7dehydrocholesterol reductase (DHCR7) were all upregulated in LDs of ethanol-fed rats but they fell to
control levels in 7-day refed animals. In ethanol-fast
LDs, except for HS17β11, DHCR7, TM7SF2, and
cytochrome P4502E1, which significantly declined
compared with ethanol-fed LDs, all other proteins
reached control levels (Fig. 5E). Fatty acid activation
enzymes acyl-coenzyme A synthetase 5 (ACSM5) and
acyl-coenzyme A synthetase 1 (ACSM1) were upregulated in LDs of ethanol-fed and ethanol-fast rats but
normalized in LDs of 7-day refed rats. Compared with
controls, fatty acid β oxidation proteins, peroxisomal
acyl-coenzyme A oxidase 3, peroxisomal acyl-coenzyme
A oxidase 1, and hepatic TG lipase were downregulated
in LDs of both ethanol-fed and ethanol-fast animals.
However, all these proteins returned to control levels in
LDs of 7-day refed animals (Fig. 5E). Interestingly, LD
acid hydrolase and ATGL (a.k.a. PNPLA2) that break
down LDs were elevated in LDs of both ethanol-fed
and ethanol-fast rats, but in LDs of 7-day refed animals, these proteins were equal to those of controls.
Finally, ATP6V01 and V-type proton ATPase 16 kDa
proteolipid subunit, which maintain lysosomal acidification, were all lower than controls in LDs of ethanolfed rats, but they rose to control levels in LDs from
7-day refed animals. Of note, LDs from ethanol-fast
rats exhibited significant upregulation of the latter
two proteins compared with LDs from control, ethanolfed, and 7-day refed rats (Fig. 5E).
Seven-day refed and ethanol-fast LDs reversed
canonical pathways of LD membrane-associated
proteins regulated by ethanol
The heat map shown in Fig. 5E indicates that 7-day
refeeding or 48-h fasting of ethanol-fed rats (ethanolfast) attenuated ethanol-induced elevations of major
LD proteins of lipid metabolism. Next, to determine the
pathways to which proteins assigned by IPA are
affected, we conducted the IPA of all proteins whose
levels were significantly altered, from those of controls
in all other groups. Pathways identified by IPA are
shown in orange, blue, white, and gray bars (Fig. 6). The
intensities of orange and blue indicate the degree of
upregulation and downregulation, respectively, of the
indicated pathway. White bars indicate no significant
changes compared with control. The IPA revealed that
LD proteins upregulated by ethanol feeding belong
predominantly to cholesterol and steroid hormone
biosynthetic pathways, whereas LD proteins downregulated by ethanol feeding belong predominantly to
oxidative phosphorylation pathways (Fig. 6A). In LDs
from 7-day refed animals, no activity score was assigned
to many pathways such as cholesterol biosynthesis, nuclear factor erythroid 2-related factor 2-mediated
oxidative stress response, and fatty acid beta oxidation,
as all these pathways returned to control levels (Fig. 6B).

Fasting of control rats (control fast) activated acetone
degradation, melatonin degradation, and estrogen and
stearate biosynthesis, whereas it downregulated
cholesterol biosynthesis and fatty acid oxidation
(Fig. 6C). Fasting of ethanol-fed rats (ethanol-fast) activated degradation pathways, for acetone, melatonin,
and serotonin and activated the nuclear factor
erythroid 2-related factor 2-mediated oxidative stress
response and oxidative phosphorylation, but fasting
downregulated cholesterol biosynthesis. Because the
IPA did not predict the status of mitochondrial function in ethanol-fed, 7-day refed, and ethanol-fast
groups, we used LDs to quantify the changes in mitochondrial proteins. Ethanol feeding downregulated 38
distinct proteins that participate in the mitochondrial
pathway. LDs from 7-day refed and ethanol-fast animals each showed restored mitochondrial function that
was previously suppressed in LDs of ethanol-fed rats
(Supplemental Table S8). To confirm the latter proteomic findings, we subjected LD fractions to SDSPAGE/WB analysis. Ethanol feeding indeed reduced
the levels of voltage-dependent anion channel and
synaptosomal-associated protein 23 required for LD
interaction
with
the
mitochondrion
(27–29)
(Supplemental Fig. S2). Both refeeding the control diet
to and fasting of ethanol-fed rats restored these proteins to control levels.
Fasting or refeeding after ethanol withdrawal each
promoted lipid utilization and mitochondrial
function
Seven-day refeeding of the control diet to or 48-h
fasting of ethanol-fed rats each reversed ethanolinduced cholesterol biosynthesis and mitochondrial
dysfunction, to suggest that each of these dietary adjustments improved hepatic lipid utilization after ethanol
withdrawal. To further examine how 7-day refeeding and
ethanol-fast affected lipid metabolism. We reviewed the
IPA data analysis for BF categories regulated by these
post-ethanol feeding treatments. Compared with controls,
none of the BF categories was significantly altered in LDs
of 7-day-refed rats (data not shown). However, ethanol
feeding modulated (increased or decreased) 43 different
LD-associated lipid-metabolizing proteins to elevate
intracellular lipids (Table 1, Fig. 7A), but ethanol feeding
also caused a decline in LD proteins that carry out carboxylic acid and ion transport (Table 1). In LDs of ethanolfast rats, activated LD membrane-associated proteins
promote: (1) lipid hydroxylation, during which fatty acids
are converted to long-chain dicarboxylic acids, preferentially metabolized by the peroxisome beta-oxidation system and subsequently by mitochondria; (2) conjugation of
eicosanoids (long-chain polyunsaturated fatty acids), a
process that leads to their catabolism; (3) exocytosis; and
(4) secretory pathway, both of which are predominantly
executed by the Rab family and other vesicle-trafficking
proteins (Table 2), which also participate in LD catabolism
via lysosome-dependent lipophagy. Of note, the number
Ethanol and hepatic lipid droplet proteome
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Fig. 6. Canonical pathways of LD membrane proteins regulated by ethanol are reversed by refeeding (7-days) and fasting after
ethanol withdrawal. Changes induced by (A) ethanol, (B) 7-day refeeding after ethanol withdrawal, (C) control fast, and (D) ethanol
fast to commonly identified canonical pathways (among enriched top 25) determined by IPA. Positive Z-score indicates upregulated
and negative Z-score indicates downregulated proteins, all versus control, which are shown in orange and blue bars (shades),
respectively. White bars indicate no change compared with the control. Gray bars indicate activities not predicted. IPA, ingenuity
pathway analysis; LD, lipid droplet.
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TABLE 1.

Biological function categories altered by chronic ethanol feeding
Control Versus Ethanol

Categories

Diseases or
Functions
Annotation

P-Value

Predicted
Activation
State

Activation
Z-Score

Lipid
metabolism

Concentration
of lipids

5.82E-09

Increased

2.273

Molecular
transport
Molecular
transport

Transport of
carboxylic acid
Transport of ion

9.49E-09

Decreased

−2.091

6.23E-06

Decreased

−2.204

Molecules

# Molecules

Abcb11,Abcc2,Abcc3,Abhd6,Apoc4,Asgr2,Atp7b,Ccny,
Ceacam1,Cideb,Clu,Cr1l,Cyp17a1,Cyp2e1,Dhcr7,Dio1,
Egfr,Epb41,Fdft1,Fmo5,Gna11,Gnaq,Hsd17b4,Itgb3,
Lima1,Mgll,Pctp,Pitpna,Plin3,Plin5,Pnpla2,Prkcd,
Ptpmt1,Rab7a,Rgn,Sc5d,Slc22a1,Slc9a3r1,Slco1a1,
Steap4,Uqcrfs1,Vac14,Xdh
Abcb11,Abcc2,Abcc3,Atp7b,Bsg,Cpt2,Prkcd,Slc16a4,
Slc23a1,Slc25a1,SlSlc26a1,Slco1a1,Slco1a4
Abcc2,Abcc3,Ano10,Atp2b1,Atp6v0a1,Atp7b,Ca3,
Coro1a,Gjb1,Nnt,Nsf,Rab11b,Slc17a2,Slc22a1,
Slc23a1,Slc26a1,Slc9a3r1,Slco1a1,Slco1a4,Steap4,
Stim1,Vdac2

43

13
22

IPA, ingenuity pathway analysis; LD, lipid droplet.
The status of enriched biological function categories of LD-associated proteins altered by ethanol feeding based on Z-scores assigned by
the IPA.

of proteins (43) that promoted lipid accumulation in LDs
of ethanol-fed rats was reduced to less than half (18) in
ethanol-fast animals (Tables 1 and 2, Fig. 7B). Ethanol fast
simultaneously decreased carboxylic acid transport and
fatty acid transport, pathways, largely regulated by related
fatty acid trafficking proteins (Table 2). Next, we reviewed
the hepatic steatosis functional annotation category and
found that ethanol feeding modulated more proteins
(orange dashed arrows) that contribute to hepatic steatosis
and received a positive Z-score by IPA, indicating upregulation of steatosis (Fig. 7C). The IPA of hepatic steatosis
category for ethanol-fasted rats revealed that this treatment modulated more proteins that inhibit (blue dashed
arrows) hepatic steatosis. This received a negative Z-score,
indicating attenuation of fatty liver (Fig. 7D). Finally, to
confirm that mitochondrial function was restored after
7-day refeeding and/or ethanol fast, as observed earlier
(Supplemental Table S8), we stained liver tissue from all
five groups of animals for mitochondrial COXIV and for
Plin-2, and we quantified total mitochondria by their
staining around LDs. Compared with livers of control rats,
livers of ethanol-fed animals exhibited significantly lower
mitochondrial staining overall, as well as around LDs
(Fig. 7E–G). However, in livers of 7-day refed and ethanolfast rats, total mitochondria and their staining around
lipid droplets were restored to normal (control) levels
(Fig. 7E–G). We then quantified mitochondrial complex I
activity in mitochondria-enriched fractions. Compared
with controls, EtOH feeding decreased mitochondrial
complex I activity by two-fold (Fig. 7H), while complex I
activity in enriched fractions from 7-days refed and
EtOH-fast rat livers were both equal to controls (Fig. 7H).
7-days refeeding and fasting after EtOH withdrawal
promoted mitochondria and lysosome function by
restoring nuclear levels of transcription factor EB
(TFEB)
Using microscopic examination and assay of lysosomal
acid lipase (LAL) activity in lysosome enriched fractions,

we found that 7-days refeeding and EtOH-fast reversed
the EtOH-elicited reduction in lysosome function (Figs. 2,
5E). Compared with controls, the livers of EtOH-fed rats
exhibited significantly lower lysosome numbers, as
judged by LAMP-1 staining around (Fig. 8A–C). Sevenday refeeding and ethanol fast, both after ethanol withdrawal, each restored total lysosomes and their staining
around LDs (Fig. 8A–C). LAL activity in lysosomeenriched fractions from ethanol-fed rats was 1.5-fold
lower than in fractions from controls (Fig. 8D). LAL activity in lysosome fractions from 7-day refed animals was
significantly higher than those from ethanol-fed rats, but
lower than control animals. LAL activities in control-fast
and ethanol-fast lysosomal fractions were comparable to
those of controls (Fig. 8D). In livers of ethanol-fed rats, the
nuclear content of transcription factor EB (TFEB), which
transcriptionally regulates genes that encode proteins of
lysosome and mitochondrial biogenesis (30), was 2-fold
lower than controls (Fig. 8E). Nuclear TFEB levels were
restored to control levels in livers of 7-day refed and
ethanol-fast rats.

DISCUSSION
Long perceived as inert fat-storing intracellular vesicles, LDs gained attention for their role in regulating
energy homeostasis in healthy liver cells and their
oversupply in unhealthy hepatocytes of rodents or
humans with alcohol- or diet-induced fatty liver (31).
Recent understanding of LD biology reveals that the
lipid and protein compositions of LDs are highly dynamic. Both influence intrinsic LD metabolism and
signaling properties, which ultimately link them to
changes in other cellular organelles (6, 8, 18). Here, we
used a rat model of chronic alcohol feeding, and we
report changes in the hepatic LD membrane-associated
proteome induced by alcohol (ethanol) administration,
which influences LD membrane proteome remodeling
after ethanol withdrawal and abstinence. Specifically,
Ethanol and hepatic lipid droplet proteome
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Fig. 7. Fasting after ethanol withdrawal reduces lipids and restores mitochondrial function. Network analysis of proteins that
contribute to (A and B) lipid concentration and (C and D) hepatic steatosis in LDs of ethanol-fed rats and ethanol-fed rats fasted after
ethanol withdrawal by IPA. Upregulated proteins are highlighted in red and downregulated proteins are highlighted in green. The
orange dashed line indicates leading to activation while the blue dashed line indicates leading to inhibition of indicated pathway
indicated. (D) Immunostaining of liver sections with antibody to mitochondrial marker protein COXIV (red) and lipid droplet
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TABLE 2.

Biological function categories modulated by fasting of ethanol-fed (ethanol-fast) rats
Control Versus Ethanol Fasted

Categories

Diseases or
Functions
Annotation

P-value

Predicted
Activation
State

Activation
Z-Score

Molecules

# Molecules

Lipid
metabolism
Lipid
metabolism

Hydroxylation
of lipid
Concentration
of fatty acids

5.5E-11

Increased

2.127

Cyb5a,Cyp27a1,Cyp2e1,Cyp4b1,

7.88E-08

Increased

2

Lipid
metabolism
Lipid
metabolism

Conjugation of
eicosanoid
Conjugation of 12hydroxyeicosatetraenoic
acid
Exocytosis by cells

3.83E-07

Increased

2.219

Abcd1,Abcg2,Casp1,Cyp27a1,Cyp2e1,
Decr1,Egfr,Faah,Fads2,G0s2,Gna11,
sd17b4,Pck1,Pcp,Pnpla2,Ptgs1,Scarb1,
Slc2a2
Faah,Ugt1a1,Ugt2b10

6.21E-06

Increased

2

Ugt1a1,Ugt2b10

2

1.75E-05

Increased

2.442

Arf6,Napa,Rab21,Rab5a,Rab9a,Rhoa

6

Secretory pathway

6.77E-05

Increased

2.428

9

Exocytosis

0.000125

Increased

2.428

Transport of
carboxylic acid

1.96E-12

Decreased

−2.09

Transport of fatty
acid

1.16E-09

Decreased

−2.182

Arf6,Napa,Prkcd,Rab11b,Rab21,Rab5a,
Rab9a,Rhoa,Sptbn2
Arf6,Napa,Prkcd,Rab21,Rab5a,Rab9a,
Rhoa,Sptbn2
Abcb11,Abcc2,Abcc3,Abcc6,Abcd1,Abcd3,
Abcg2,Alb,Ca14,Cpt2,Prkcd,Scarb1,
Slc16a2,Slc23a1,Slc26a1,Slc27a2,Slc2a2,
Slco1a1,Slco1a4
Abcc2,Abcc3,Abcc6,Abcd1,Abcd3,Abcg2,Alb,
Cpt2,Prkcd,Scarb1,Slc27a2,Slco1a1,Slco1a4

Cellular
function
Cellular
function
Cellular
function
Molecular
transport
Lipid
metabolism

4
18

3

8
19
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IPA, ingenuity pathway analysis; LD, lipid droplet.
Status of enriched biological function categories of LD-associated proteins modulated by fasting of ethanol-fed rats, based on Z-scores
assigned by the IPA.

the ethanol diet was either replaced with control diet or
the animals were fasted for 48 h. In short, ethanol
feeding promoted fatty liver, whereas subsequent
refeeding of the control diet or fasting either fully or
partially resolved steatosis.
The ethanol-induced hepatic accumulation of LDs
(Fig. 1A) was associated with elevated hepatic TGs and
serum NEFAs in these animals (Fig. 1B, C). NEFAs are
major contributors to hepatic TG accumulation
because they are rapidly taken up by hepatocytes and
esterified with glycerol, forming TGs (2). As seen here,
NEFA levels were completely normalized by 7-day
refeeding but not by ethanol fast. Fasting induces
adipose tissue lipolysis, which mobilized fatty acids
from adipose tissue (32) into the sera of control-fast
and ethanol-fast rats (Fig. 1C). Despite ethanol withdrawal, fasting of these animals likely replenished
serum NEFA levels, thereby mitigating the complete
attenuation of fatty liver after ethanol withdrawal.
Although fasting ethanol-fed rats did not decrease
serum NEFA levels, both it and 7-day refeeding
enriched the contents of LD-associated proteins that
are critical for reducing lipid accumulation (Fig. 2),
thereby alleviating ethanol-induced fatty liver (Fig. 1A,
B). Such alleviation included reductions in the
amounts of (1) LD PLINs 3 and 5, the structural

proteins that fortify LDs to prevent their breakdown
(23); (2) hydroxysteroid proteins HSD17β13 and 11, both
enzymes are involved in cholesterol and fatty acid
metabolism and promote fatty liver in humans and
animals (20, 21), and (3) CIDEB of the CIDE family of
proteins, which promotes LD fusion to create larger
LDs (18). In addition, fasting (ethanol fast) and 7-day
refeeding after ethanol withdrawal both restored (1)
the active forms of HSL and ATGL, lipases which
break down larger LDs to smaller LDs, thereby facilitating lipophagy (33) and (2) LAMP1 and LAMP2A
levels, both indicating enhanced interaction of lysosomes with LDs, thereby enhancing macrolipophagy
and chaperone-mediated autophagy. Differential
regulation/expression of these latter proteins on the
surfaces of LDs reflects the degree of fatty liver after
subjecting rats to the aforementioned treatments.
These data lead us to suggest that LD membraneassociated proteins participate directly in regulating
LD size and LD turnover (synthesis and degradation).
GO analyses of LD proteins from pair-fed control
rats, identified by MS, revealed that LD membrane
proteins' BFs are largely grouped under sterol and fatty
acid biosynthetic pathways, fatty acid beta oxidation,
electron transport, oxidative phosphorylation, oxidoreductase activity, and vesicle trafficking. Moreover, a

marker protein Plin-2 (green), from rats treated, as indicated. Fluorescence intensity quantification by ImageJ of (F) total mitochondrial staining and (G) mitochondrial staining around lipid droplets. (H) Mitochondrial complex I activity in mitochondria
isolated from livers of rats treated as indicated on the graph. COXIV, cytochrome c oxidase subunit IV; IPA, ingenuity pathway
analysis; LD, lipid droplet; PLIN, perilipin.
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Fig. 8. Refeeding and fasting after ethanol withdrawal promoted mitochondria and lysosomal function by restoring nuclear levels
of transcription factor EB (TFEB). A: Immunostaining of liver sections with the antibody to lysosomal marker protein LAMP1 (red)
and lipid droplet marker protein Plin-2 (green), from rats treated, as indicated. Fluorescence intensity quantification by ImageJ of (B)
total lysosomal staining, (C) lysosomal staining around lipid droplets, and (D) specific activity of LAL in lysosomes isolated from livers
of rats treated as indicated on the graph. E: TFEB in nuclear fractions. Data are the means ± SE of 6–8 animals/group. Bars with
different letters are significantly different. Bars with the same letter are not significantly different, P ≤ 0.05. LAL, lysosomal acid
lipase; LAMP, lysosome-associated membrane protein; PLIN, perilipin.

subset of these latter proteins was identified as proteins
of the mitochondrion, ER, peroxisome, and Golgi
apparatus (Fig. 3B). These data confirm widespread
microscopic data that LDs interact by direct contact
with other cellular organelles. Electron microscope
studies (34) provide visual evidence of such contacts,
which are facilitated by protein-based interorganelle
contact sites on LDs that allow trafficking-independent
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communication with other organelles to regulate LD
dynamics (6). These data indicate that LD metabolism
and turnover depends on (1) lipid-regulating proteins
that are tightly associated with LDs and (2) frequent
communication with other organelles. Here, we have
shown clear evidence that proteins associated with
other organelles and which participate in lipid metabolism by direct interaction with LDs were detected on

isolated LDs from livers of control and ethanol-fed
animals.
Chronic ethanol feeding altered 338 different LD
membrane-associated proteins and induced drastic
changes in the LD proteome network (Fig. 4). Here,
our proteomic analyses identified additional proteins
associated with affected BFs, as judged by WB analyses
of LD membrane proteins (Fig. 2). Proteomic quantifications confirmed our WB data that ethanol feeding
elevated the levels of PLIN-3, PLIN-5, CIDEB, and
HSD17β13 (Fig. 4B). Proteomics also revealed that
ethanol administration increased the levels of LSS,
squalene monooxygenase, 3-keto-steroid reductase
(HSD17β7), and several cytochrome P450 isozymes that
catalyze steroid and cholesterol biosynthesis. These
data confirm our WB quantifications (Fig. 2) of steroidogenic proteins (HSD17β11/13) that promote fatty
liver. WBs also revealed that chronic ethanol feeding
decreased the level of pATGL, while it also decreased
LAMP1, a reliable index of the lysosome content
(Fig. 2). Proteomics of LDs from ethanol-fed rats
confirmed these findings by revealing higher levels of
additional ATGL inhibitors (G0s2 and Fas-associated
factor family member 2) and lower levels of other
lysosomal proteins, including lysosomal integral
membrane protein 2 and ATP6V0A1. IPAs of all the
significantly altered proteins revealed that mitochondrial pathways were predominantly downregulated in
LDs of ethanol-fed rats (Fig. 4C, D), whereas steroid
and cholesterol biosynthetic pathways were the most
highly activated (Fig. 4C). These findings are well
aligned with previous results (9–11, 35, 36) that ethanol
feeding increases hepatic steroid and cholesterol contents while it downregulates lipases and lysosome
contents thereby slowing LD breakdown via lipolysis
and lipophagy.
Refeeding and fasting ethanol-fed rats each had
contrasting effects on the LD membrane proteome.
Compared with pair-fed control rats, 7-day refeeding
after ethanol withdrawal altered 93 proteins (Fig. 5B)
which clustered rather closely with controls on the
PCA plot (Fig. 5A), indicating that ethanol-induced
changes were reversed by refeeding (Fig. 5A). However, ethanol fast altered 448 LD proteins and these
remained very distinct from LDS of pair-fed control,
ethanol-fed and 7-day refed animals (Fig. 5A). These
findings lead us to suggest that ethanol fast operates
through a distinct mechanism to remodel ethanolinduced changes in the LD membrane proteome.
Upon analyzing more proteins, in addition to those
described above that participate in lipogenesis and
lipid catabolism, we found that ethanol feeding
induced different proteins that accelerate steroid
hormone and cholesterol biosynthesis (Fig. 5E). These
include cytochrome b5 reductase 3, DHCR7, sterol-4alpha-carboxylate 3-dehydrogenase, decarboxylating,
TM7SF2, and DHCR7 that stimulate steroid and
cholesterol biosynthesis and METTL7A, and ACSM1

and ACSM5 that enhance fatty acid activation and LD
formation. Elevations of these proteins occurred
simultaneously with decreased levels of proteins that
enhance lysosomal activity (ATP6V0A1 and SCARB1).
The latter ethanol-induced changes by were
completely reversed by 7-day refeeding with the
control diet. Although ethanol fast enhanced the
levels of ACSM1 and ACSM5, it largely attenuated or
normalized the proteins altered by ethanol, but it
markedly elevated lysosomal proteins. IPAs of canonical pathways (Fig. 6) and manual review of mitochondrial proteins (Supplemental Table S8) indicated
that both 7-day refeeding and ethanol fast reversed
the ethanol-elicited enhancement of cholesterol
biosynthesis and increased the levels of mitochondrial
proteins (Fig. 6B, D). Review of BF categories also
supported our canonical pathway analyses. BF categories in 7-day refed and ethanol-fasted animals,
compared with controls, revealed that there was no
predictable activation state in all the biological categories in 7-day refed rats, indicating that the effects of
refeeding were not significantly different and were
therefore equivalent to those from controls. However,
ethanol fast caused a 2-fold decrease in the LD levels
of ethanol-induced proteins that promote lipogenesis
(Table 2, Fig. 7A, B). Ethanol fast also enhanced the
levels of LD proteins that participate in lipid oxidation
in peroxisomes and mitochondria, and it enhanced the
levels of Rab and other vesicle-trafficking proteins,
which facilitate LD interaction with other organelles
and LD degradation in lysosomes (Table 2). These
findings indicate that, although 7-day refeeding and
ethanol fast distinctly remodeled the ethanol-induced
LD proteome, they both attenuated steroid and
cholesterol biosynthesis, restored mitochondrial proteins, and promoted lipolysis and lipophagy, both
pathways of LD degradation.
Microscopic analyses and catalytic activity measurements of mitochondria and lysosomes further
confirmed that 7-day refeeding and ethanol fast
restored the activities of these organelles to enhance
lipid breakdown (Fig. 7E, F and Fig. 8A, B). Staining of
both mitochondria and lysosomes was lower in livers
of ethanol-fed rats. Staining intensity increased after
both 7-day refeeding and ethanol fast. The latter two
interventions not only restored normal levels of
mitochondrial and lysosome makers but also normalized mitochondrial complex I activity and the levels of
LAL, both of which declined after ethanol administration (Fig. 8D). Restoration of mitochondrial and
lysosomal function correlated positively with restored
nuclear levels of TFEB, which regulates autophagy, by
enhancing the biogenesis of lysosomes and mitochondria (30) (Fig. 8E). Although ethanol administration decreased the levels of nuclear TFEB, both 7-day
refeeding and ethanol fast of ethanol-fed rats restored
its levels in rat liver nuclei. These data lead us to
suggest that 7-day refeeding and ethanol fast restored
Ethanol and hepatic lipid droplet proteome
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nuclear TFEB, which, in turn, reactivated mitochondrial and lysosomal functions. All these findings suggest that, refeeding or fasting after ethanol
withdrawal attenuated LD accumulation by reducing
the levels of LD membrane proteins that promote
lipid biosynthesis, while simultaneously promoting
those that breakdown LDs and oxidize the lipids
within, in lysosomes and mitochondria, respectively.
In summary, chronic ethanol administration
significantly altered the LD membrane-associated
proteome, enriching lipid biosynthetic proteins and
reducing lipid degrading proteins, thereby conferring
LD resistance to breakdown. These ethanol-elicited
changes were further associated with lower levels of
mitochondrial and lysosomal proteins on the LD
surface. These findings indicate reduced contents
(and activities) of these organelles in liver cells of
ethanol-fed rats. Our findings also lead us to suggest
that ethanol feeding likely disrupts the direct
communication of LDs with mitochondria and lysosomes because the biogenesis of each is reduced. The
latter events exacerbate fatty liver by slowing LD
catabolism. Seven-day refeeding or fasting of ethanolfed rats, each distinctly remodeled the ethanolmodified LD proteome by lowering lipid biosynthetic proteins and restoring LD catabolic proteins,
specifically those from mitochondria and lysosomes,
thereby alleviating ethanol-induced fatty liver.
Although both refeeding and fasting after ethanol
withdrawal attenuated ethanol-induced fatty liver,
refeeding the control diet clearly reduced unexpected complications that arose from fasting. One of
these included higher NEFA levels that caused a
slower decline in hepatic fat, which was potentially
hepatotoxic. In conclusion, our data clearly support
the notion that alcohol withdrawal, along with
adequate nutritional support, is necessary for managing alcohol-induced liver injury.
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